Advances in Endometrial Cancer

ASTRO's 59th Annual Meeting
Date: September 25, 2017
Time: 4:15 pm - 5:45 pm
 
Controversy exists as to the need for surgical staging in all patients. The proper application of adjuvant radiotherapy and chemotherapy also is a source of considerable debate. This educational session will review these controversies with special attention to the impact on patient care. The impact of adjuvant therapy on local control, survival and quality of life will be explored.

Target Audience

This continuing medical education activity is designed to meet the interests of radiation oncologists, radiation oncology residents, radiation biologists, radiation physicists, dosimetrists, oncologists working in related specialties, radiation therapists, radiation oncology nurses, radiation oncology administrators, diagnostic radiologists and all other health professionals involved in the field of radiation oncology.

Learning Objectives

After this session, attendees should be able to:

  • discuss the role of radiation therapy in early stage and advanced stage endometrial cancer.
  • explain the role of surgery and surgical staging in the management of endometrial cancer.
  • review the role of chemotherapy in the management of early and advanced stage endometrial cancer.
Course summary
Available credit: 
  • 1.50 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

Course opens: 
09/25/2017
Course expires: 
09/25/2017
Cost:
$0.00
Rating: 
0

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.50 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

Accreditation Period

Course opens: 
09/25/2017
Course expires: 
09/25/2017

Price

Cost:
$0.00
Please login or register to take this course.